MG
MRK icon

Michael Gelband’s Merck MRK Stock Holding History

Michael Gelband’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-144,655
Closed -$17.4M – 1882
2026
Q1 		$17.4M Sell
144,655
-17,252
-11% -$1.99M 0.14% 128
2025
Q4 		$17M Buy
+161,907
New +$15.2M 0.13% 128
2025
Q1 		– Sell
-91,315
Closed -$9.08M – 1801
2024
Q4 		$9.08M Buy
+91,315
New +$9.41M 0.06% 296
2024
Q3 		– Sell
-298,569
Closed -$37M – 1913
2024
Q2 		$37M Sell
298,569
-65,055
-18% -$8.38M 0.25% 59
2024
Q1 		$48M Buy
363,624
+209,969
+137% +$25.9M 0.37% 40
2023
Q4 		$16.8M Sell
153,655
-463,994
-75% -$48.2M 0.11% 128
2023
Q3 		$63.6M Buy
617,649
+213,398
+53% +$23M 0.61% 23
2023
Q2 		$46.6M Buy
404,251
+83,394
+26% +$9.47M 0.38% 37
2023
Q1 		$34.1M Buy
320,857
+147,949
+86% +$16M 0.28% 43
2022
Q4 		$19.2M Sell
172,908
-163,824
-49% -$16.7M 0.28% 75
2022
Q3 		$29M Buy
336,732
+129,842
+63% +$11.6M 0.38% 28
2022
Q2 		$18.9M Buy
206,890
+147,304
+247% +$13.1M 0.23% 79
2022
Q1 		$4.89M Buy
59,586
+29,849
+100% +$2.35M 0.06% 394
2021
Q4 		$2.28M Sell
29,737
-104,127
-78% -$8.29M 0.02% 707
2021
Q3 		$10.1M Buy
133,864
+118,826
+790% +$9.04M 0.14% 188
2021
Q2 		$1.17M Sell
15,038
-35,225
-70% -$2.62M 0.01% 921
2021
Q1 		$3.7M Buy
50,263
+29,511
+142% +$2.18M 0.05% 363
2020
Q4 		$1.62M Buy
20,752
+4,200
+25% +$321K 0.02% 630
2020
Q3 		$1.31M Buy
+16,552
New +$1.3M 0.03% 567
2020
Q2 		– Sell
-7,093
Closed -$521K – 1928
2020
Q1 		$521K Buy
+7,093
New +$557K 0.03% 472
2019
Q4 		– Sell
-6,776
Closed -$544K – 1745
2019
Q3 		$544K Sell
6,776
-3,029
-31% -$243K 0.02% 625
2019
Q2 		$785K Buy
+9,805
New +$751K 0.03% 326

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Michael Gelband's MRK Position: Q2 2026 in Review

Michael Gelband sold out of Merck (MRK) in Q2 2026, closing a stake of 144,655 shares — an estimated $17.4M sold.

Michael Gelband first reported a position in MRK in Q2 2019 and held it in 22 quarters. The position peaked at $63.6M in Q3 2023. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Michael Gelband reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 144,655 Merck shares in Q2 2026, an estimated $17.4M.
  • Michael Gelband first reported a position in Merck in Q2 2019 and held it in 22 quarters.
  • Michael Gelband's Merck position peaked at $63.6M in Q3 2023.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.